Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1112
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01106651 | A Safety and Efficacy Study of Canagliflozin in Older Patients (55 to 80 Years of Age) With Type 2 Diabetes Mellitus | ||
| NCT01776424 | Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease | ||
| NCT02477891 | Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma | ||
| NCT02920424 | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus | ||
| NCT01480388 | A Dose Range Finding Study of JNJ-39758979 in Patients With Active Rheumatoid Arthritis Currently Treated With Methotrexate | ||
| NCT05083169 | A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma | ||
| NCT05076877 | A Study of Lazertinib (JNJ-73841937) in Healthy Participants | ||
| NCT01156428 | Inflammatory and Immune Profiling of Kidney Tissue Obtained From Patients With Newly Diagnosed Kidney Disease | ||
| NCT05784129 | A Study of Guselkumab for the Treatment of Participants With Crohn's Disease After Surgical Resection | ||
| NCT03629951 | A Study for Schizophrenia Relapse Prediction | ||
| NCT02079545 | Bioavailability and Pharmacokinetics Study of Sirukumab in Healthy Male Participants | ||
| NCT04609826 | A Study of JNJ-74856665 in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) | ||
| NCT05083078 | A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis | ||
| NCT02569398 | An Efficacy and Safety Study of Atabecestat in Participants Who Are Asymptomatic at Risk for Developing Alzheimer's Dementia | ||
| NCT06919965 | A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer | ||
| NCT03755128 | A Study to Characterize the Clinical Course of Pregnant Women and Children at High Risk for Early Onset Severe Hemolytic Disease of the Fetus and Newborn | ||
| NCT05307692 | A Study of Seltorexant in Participants With Probable Alzheimer's Disease | ||
| NCT01628692 | Study of Daclatasvir (BMS-790052) and Simeprevir (TMC435) in Patients With Genotype 1 Chronic Hepatitis C Virus | ||
| NCT02933580 | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-56136379 in Healthy Japanese Adult Participants | ||
| NCT02421185 | Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma | ||
| NCT03655223 | Early Check: Expanded Screening in Newborns | ||
| NCT07227025 | A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer | ||
| NCT05884242 | A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge | ||
| NCT02743546 | Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in Lymphoma | ||
| NCT00473746 | Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancer | ||
| NCT01627782 | A Study of Ketamine in Patients With Treatment-resistant Depression | ||
| NCT05014360 | A Study of JNJ-64251330 in Participants With Familial Adenomatous Polyposis | ||
| NCT04919512 | A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder | ||
| NCT03652064 | A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy | ||
| NCT03952507 | A Study to Assess the Relative Oral Bioavailability and Food Effect of Single-dose of JNJ-64417184 in Healthy Participants | ||
| NCT07032714 | Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma | ||
| NCT01384630 | Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis | ||
| NCT03965741 | Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners | ||
| NCT05092269 | A Long-term Extension Study of Ustekinumab in Pediatric Participants | ||
| NCT03451851 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants | ||
| NCT02692677 | A Study to Assess the Absorption, Metabolism, and Routes of Excretion Following Oral Administration of (14C) Radiolabeled JNJ--42756493 to Healthy Male Participants | ||
| NCT01988961 | A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis | ||
| NCT06649695 | A Phase II Trial of Teclistamab in Participants With Previously Treated Immunoglobulin Light-chain (AL) Amyloidosis | ||
| NCT05268497 | A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression | ||
| NCT01887535 | A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-54861911 in Healthy Elderly Participants | ||
| NCT07029776 | MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma | ||
| NCT02742623 | A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active Cancer | ||
| NCT04617691 | A Study of Intravenous Formulation of Guselkumab Using Prefilled Syringes and Final Vialed Product in Healthy Participants | ||
| NCT06385080 | A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer | ||
| NCT03010059 | A Study to Assess the Relative Bioavailability of JNJ64041575 Administered as 2 Different New Concept Formulations (Oral Suspension and Tablet) Compared to Their Respective Current Formulations, and to Assess the Effect of Food on the Pharmacokinetics of the 2 New Concept Formulations | ||
| NCT03277755 | A Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Odalasvir and AL-335 Alone and in Combination With Simeprevir in Participants With Moderately Impaired Hepatic Function | ||
| NCT02345148 | Pharmacokinetic, Safety, and Tolerability Study of Intranasally Administered Esketamine in Elderly and and Healthy Younger Adult Participants | ||
| NCT07223125 | A Study of JNJ-89862175 for Treatment of Advanced Solid Tumors | ||
| NCT05957276 | Global Patient Registry of Inherited Retinal Diseases | ||
| NCT06178614 | A Study of JNJ-87890387 for Advanced Solid Tumors |
